Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Steroid use for patients with brain metastases and spinal cord compression

Dr Fay Murray-Brown
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.15-1-106c
Clin Med February 2015
Dr Fay Murray-Brown
AHospiscare, Exeter, UK
Roles: ST4 palliative medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – I read with interest ‘Brain metastases’ (Clin Med 2014;14:535–7) and ‘Metastatic spinal cord compression: a rare but important complication of cancer’ (Clin Med 2014;14:542–5). I would like to make a few further points regarding the use of steroids. Spencer et al advise high-dose dexamethasone for patients with brain metastases, with a suggested regimen of 16 mg daily, reducing to a maintenance dose of 2–4 mg daily. Dexamethasone provides symptomatic relief for patients with raised intracranial pressure from cerebral oedema but this relief reduces over time and undesirable side effects increase. Thus, ideally, the dose of dexamethasone should be discontinued after 2–4 weeks.1 No benefit is seen in patients with asymptomatic brain metastases.2 Robson advises administering 16 mg dexamethasone daily if metastatic cord compression is suspected, but eventual steroid reduction is not discussed. Following radiotherapy or surgery, steroids should be tailed off gradually and completely over 4–6 weeks, or to the lowest dose that maintains stability. Corticosteroids may result in a rapid improvement of neurological function but long-term benefit is limited, and there is no evidence that survival is improved.3 High-dose, long-duration treatment with corticosteroids causes significant side effects which can be debilitating and occasionally fatal. For those patients who do not proceed to surgery or radiotherapy, dexamethasone should be reduced gradually and stopped. We undertook an audit of the patients known to St Luke's Hospice in Plymouth in a six-month period this year (n = 1,152), and found one-third of them had taken steroids. Oncologists had prescribed steroids in nearly half of cases. 20% of patients were taking steroids for brain metastases and 10% for spinal cord compression. Steroid dose was not regularly reviewed and patients often remained on steroids for far too long, resulting in 40% of patients suffering side-effects, most commonly proximal myopathy and peripheral oedema. 50% of patients were taking steroids until their death. GPs and palliative nurse specialists are often underconfident in reducing and stopping steroid courses and therefore clear guidance needs to be given to indicate duration of steroid course and plans for reduction.

  • © 2015 Royal College of Physicians

References

  1. 1.↵
    1. Vecht CJ,
    2. Hovestadt A,
    3. Verbiest HB,
    4. van Vliet JJ,
    5. van Putten WL
    . Dose effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumours. A randomised study of doses of 4, 8 and 16mg per day Neurology 1994;44:675-80.doi:10.1212/WNL.44.4.675
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Twycross R,
    2. Wilcock A
    (eds). Palliative care formulary, 4th edn. Nottingham: Palliativedrugs.com Ltd, 2011.
  3. 3.↵
    1. National Institute for Health and Clinical Excellence
    . Metastatic spinal cord compression: diagnosis and management of patients at risk of or with metastatic spinal cord compression London: NICE, 2008.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Steroid use for patients with brain metastases and spinal cord compression
Dr Fay Murray-Brown
Clinical Medicine Feb 2015, 15 (1) 106; DOI: 10.7861/clinmedicine.15-1-106c

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Steroid use for patients with brain metastases and spinal cord compression
Dr Fay Murray-Brown
Clinical Medicine Feb 2015, 15 (1) 106; DOI: 10.7861/clinmedicine.15-1-106c
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides
  • Response
  • Functional disorders and chronic pain
Show more Letters to the editor

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians